ml-291

ML291 is a sufonamidebenzamide compound that induces the unfolded protein response (UPR) and overwhelms the adaptive capacity of UPR, resulting in apoptosis in various solid cancer models. It activates the PERK eIF2a CHOP apoptotic pathway of UPR and reduces leukemic cell burden [1].